Terms: = Germ cell tumor AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4
119 results:
1. Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells.
Saamarthy K; Ahlqvist K; Daams R; Balagunaseelan N; Rinaldo-Matthis A; Kazi JU; Sime W; Massoumi R
BMC Cancer; 2024 Jan; 24(1):103. PubMed ID: 38238702
[TBL] [Abstract] [Full Text] [Related]
2. Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum-based chemotherapy.
Breekveldt ECH; Ykema BLM; Bisseling TM; Moons LMG; Spaander MCW; Huibregtse IL; van der Biessen-van Beek DTJ; Mulder SF; Saveur L; Kerst JM; Zweers D; Suelmann BBM; de Wit R; Reijm A; van Baalen S; Butterly LF; Hisey WM; Robinson CM; van Vuuren AJ; Carvalho B; Lansdorp-Vogelaar I; Schaapveld M; van Leeuwen FE; Snaebjornsson P; van Leerdam ME
Int J Cancer; 2024 Apr; 154(8):1474-1483. PubMed ID: 38151749
[TBL] [Abstract] [Full Text] [Related]
3. County-level disparities in care for patients with glioblastoma.
Ramapriyan R; Ramesh T; Yu H; Richardson LG; Nahed BV; Carter BS; Barker FG; Curry WT; Choi BD
Neurosurg Focus; 2023 Nov; 55(5):E12. PubMed ID: 37913538
[TBL] [Abstract] [Full Text] [Related]
4. Clinical presentation of MEN 2A in index vs. non-index patients.
Machens A; Lorenz K; Weber F; Brandenburg T; Führer-Sakel D; Dralle H
Endocrine; 2023 Nov; 82(2):450-455. PubMed ID: 37477781
[TBL] [Abstract] [Full Text] [Related]
5. MRI characteristics predict BRAF V600E status in gangliogliomas and pleomorphic xanthoastrocytomas and provide survival prognostication.
Jiang B; Zheng Y; She D; Xing Z; Cao D
Acta Radiol; 2024 Jan; 65(1):33-40. PubMed ID: 37401109
[TBL] [Abstract] [Full Text] [Related]
6. Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid tumors.
Liu Y; Mullangi S; Debono D; Chen X; Pham T; Fisch MJ; Gordon AS; Hershman DL
JCO Oncol Pract; 2023 Sep; 19(9):731-740. PubMed ID: 37384847
[TBL] [Abstract] [Full Text] [Related]
7. Intravitreal Topotecan 90 µg for Recurrent Solid Retinoblastoma tumors Is Effective and Not Toxic.
Abramson DH; Francis JH
J Pediatr Ophthalmol Strabismus; 2023; 60(2):e16-e18. PubMed ID: 36975114
[TBL] [Abstract] [Full Text] [Related]
8. Additional malignancies and mortality in uveal melanoma: A 20-year follow-up of a Norwegian patient cohort.
Robsahm TE; Falk RS; Eide NA
Acta Ophthalmol; 2023 Sep; 101(6):696-704. PubMed ID: 36924309
[TBL] [Abstract] [Full Text] [Related]
9. Smoking as a prognostic factor for survival in patients with disseminated germ cell cancer.
Bandak M; Nielsen KS; Kreiberg M; Wagner T; Rosenvilde J; Pissinger C; Johansen C; Daugaard G; Lauritsen J
J Natl Cancer Inst; 2023 Jun; 115(6):753-756. PubMed ID: 36806937
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic Factors and Treatment Impact on Overall Survival in Adult Craniopharyngioma.
Awad M; Butterfield JT; Dhawan S; Tyler MA; Venteicher AS
World Neurosurg; 2023 May; 173():e132-e139. PubMed ID: 36773809
[TBL] [Abstract] [Full Text] [Related]
11. Radiomics features based on MRI predict BRAF V600E mutation in pediatric low-grade gliomas: A non-invasive method for molecular diagnosis.
Xu J; Lai M; Li S; Ye K; Li L; Hu Q; Ai R; Zhou J; Li J; Zhen J; Cai L; Shi C
Clin Neurol Neurosurg; 2022 Nov; 222():107478. PubMed ID: 36244075
[TBL] [Abstract] [Full Text] [Related]
12. Investigation of radiomics based intra-patient inter-tumor heterogeneity and the impact of tumor subsampling strategies.
Henry T; Sun R; Lerousseau M; Estienne T; Robert C; Besse B; Robert C; Paragios N; Deutsch E
Sci Rep; 2022 Oct; 12(1):17244. PubMed ID: 36241749
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathological, Oncogenic, and
Chen Y; Dong Y; Shi J; Zhao L
Contrast Media Mol Imaging; 2022; 2022():1926797. PubMed ID: 35821888
[TBL] [Abstract] [Full Text] [Related]
14. A Nomogram for Predicting Early Recurrence in Patients with High-Grade Gliomas.
Zhou Q; Ke X; Xue C; Li S; Huang X; Zhang B; Zhou J
World Neurosurg; 2022 Aug; 164():e619-e628. PubMed ID: 35589036
[TBL] [Abstract] [Full Text] [Related]
15. Identification of distinct genomic features reveals frequent somatic AHNAK and PTEN mutations predominantly in primary malignant melanoma presenting in the ureter.
Huang Y; Wei L; Huang Y; Wen S; Liu T; Duan X; Wang Y; Zhang H; Fan B; Hu B
Jpn J Clin Oncol; 2022 Aug; 52(8):930-943. PubMed ID: 35578896
[TBL] [Abstract] [Full Text] [Related]
16. The immune regulation of bcl3 in glioblastoma with mutated IDH1.
Fan S; Wu N; Chang S; Chen L; Sun X
Aging (Albany NY); 2022 Apr; 14(9):3856-3873. PubMed ID: 35488886
[TBL] [Abstract] [Full Text] [Related]
17. Population-based incidence of intraocular tumours in Olmsted County, Minnesota.
Oyemade KA; Xu TT; Lopez Dominguez J; Dumbrava MG; Hodge DO; White LJ; Dalvin LA
Br J Ophthalmol; 2023 Sep; 107(9):1369-1376. PubMed ID: 35450938
[TBL] [Abstract] [Full Text] [Related]
18. [Value of tumor growth rate in evaluating the early therapeutic efficacy of neuroendocrine neoplasm].
Zhou YT; Xia YF; Li Y; Zhu YJ; Chi Y; Jiang L
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1000-1006. PubMed ID: 35399019
[No Abstract] [Full Text] [Related]
19. Comparison of artefact reduction possibilities with the new active transcutaneous bone conduction implant (Bonebridge).
Edlinger S; Tenner E; Frühwald J; Sprinzl G
J Laryngol Otol; 2023 Mar; 137(3):263-269. PubMed ID: 35144697
[TBL] [Abstract] [Full Text] [Related]
20. Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed cell Death 1 and Anti-Programmed cell Death Ligand 1 Therapy.
Tang K; Seo J; Tiu BC; Le TK; Pahalyants V; Raval NS; Ugwu-Dike PO; Zubiri L; Naranbhai V; Carrington M; Gusev A; Reynolds KL; LeBoeuf NR; Asgari MM; Kwatra SG; Semenov YR
JAMA Dermatol; 2022 Feb; 158(2):189-193. PubMed ID: 35019948
[TBL] [Abstract] [Full Text] [Related]
[Next]
